Replimune Group Inc (REPL)
10.80
-0.60
(-5.26%)
USD |
NASDAQ |
Nov 15, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Price to Book Value: 1.937 for Nov. 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 1.937 |
| November 14, 2024 | 2.045 |
| November 13, 2024 | 2.097 |
| November 12, 2024 | 2.186 |
| November 11, 2024 | 2.242 |
| November 08, 2024 | 2.231 |
| November 07, 2024 | 2.189 |
| November 06, 2024 | 2.277 |
| November 05, 2024 | 2.155 |
| November 04, 2024 | 2.155 |
| November 01, 2024 | 2.134 |
| October 31, 2024 | 2.108 |
| October 30, 2024 | 2.171 |
| October 29, 2024 | 2.202 |
| October 28, 2024 | 2.160 |
| October 25, 2024 | 2.103 |
| October 24, 2024 | 2.144 |
| October 23, 2024 | 2.153 |
| October 22, 2024 | 2.146 |
| October 21, 2024 | 2.035 |
| October 18, 2024 | 2.067 |
| October 17, 2024 | 2.028 |
| October 16, 2024 | 2.046 |
| October 15, 2024 | 1.890 |
| October 14, 2024 | 1.913 |
| Date | Value |
|---|---|
| October 11, 2024 | 2.058 |
| October 10, 2024 | 1.994 |
| October 09, 2024 | 2.112 |
| October 08, 2024 | 2.105 |
| October 07, 2024 | 2.031 |
| October 04, 2024 | 2.073 |
| October 03, 2024 | 2.096 |
| October 02, 2024 | 2.20 |
| October 01, 2024 | 2.134 |
| September 30, 2024 | 1.965 |
| September 27, 2024 | 1.788 |
| September 26, 2024 | 1.783 |
| September 25, 2024 | 1.774 |
| September 24, 2024 | 1.774 |
| September 23, 2024 | 1.756 |
| September 20, 2024 | 1.748 |
| September 19, 2024 | 1.799 |
| September 18, 2024 | 1.775 |
| September 17, 2024 | 1.767 |
| September 16, 2024 | 1.676 |
| September 13, 2024 | 1.783 |
| September 12, 2024 | 1.663 |
| September 11, 2024 | 1.661 |
| September 10, 2024 | 1.657 |
| September 09, 2024 | 1.687 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8216
Minimum
May 29 2024
9.258
Maximum
Dec 01 2020
2.687
Average
2.412
Median
Price to Book Value Benchmarks
| Bristol-Myers Squibb Co | 6.652 |
| Nuvalent Inc | 5.506 |
| NovaBay Pharmaceuticals Inc | 3.267 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.9236 |
Price to Book Value Related Metrics
| Price | 10.80 |
| Earnings Yield | -28.24% |
| Market Cap | 738.91M |